30 years of historical data (1996–2025) · Healthcare · Medical - Instruments & Supplies
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Pro-Dex, Inc. trades at 21.5x earnings, 9% above its 5-year average of 19.8x, sitting at the 62nd percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.3x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $184M | $147M | $70M | $69M | $60M | $120M | $73M | $56M | $29M | $25M | $23M |
| Enterprise Value | $200M | $163M | $81M | $81M | $75M | $135M | $73M | $53M | $24M | $21M | $21M |
| P/E Ratio → | 21.51 | 16.34 | 32.73 | 9.79 | 13.18 | 27.04 | 11.88 | 13.38 | 17.97 | 4.92 | 27.80 |
| P/S Ratio | 2.76 | 2.20 | 1.30 | 1.51 | 1.43 | 2.86 | 2.09 | 2.05 | 1.29 | 1.14 | 1.15 |
| P/B Ratio | 5.27 | 4.00 | 2.27 | 2.20 | 2.36 | 4.73 | 3.81 | 3.28 | 1.67 | 1.83 | 2.61 |
| P/FCF | — | — | 13.45 | 15.48 | — | — | 13.63 | 28.94 | 13.36 | 9.66 | 177.14 |
| P/OCF | — | — | 11.31 | 12.72 | — | — | 12.32 | 16.77 | 9.33 | 7.75 | 49.80 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Pro-Dex, Inc.'s enterprise value stands at 16.8x EBITDA, 17% above its 5-year average of 14.3x. The Healthcare sector median is 14.5x, placing the stock at a 16% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.45 | 1.51 | 1.76 | 1.79 | 3.22 | 2.10 | 1.94 | 1.06 | 0.96 | 1.04 |
| EV / EBITDA | 16.79 | 13.65 | 9.73 | 12.29 | 12.85 | 23.15 | 9.54 | 9.68 | 8.05 | 6.38 | 18.59 |
| EV / EBIT | 18.73 | 12.64 | 25.39 | 8.16 | 12.20 | 21.99 | 9.00 | 10.54 | 6.97 | 7.37 | 18.01 |
| EV / FCF | — | — | 15.54 | 18.12 | — | — | 13.74 | 27.29 | 10.98 | 8.08 | 160.18 |
Margins and return-on-capital ratios measuring operating efficiency
Pro-Dex, Inc. earns an operating margin of 16.1%. Operating margins have expanded from 12.5% to 16.1% over the past 3 years, signaling improving operational efficiency. ROE of 26.6% indicates solid capital efficiency. ROIC of 17.0% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.3% | 29.3% | 27.0% | 27.7% | 31.2% | 31.2% | 37.7% | 36.0% | 35.4% | 32.7% | 26.8% |
| Operating Margin | 16.1% | 16.1% | 13.3% | 12.5% | 12.2% | 12.2% | 20.3% | 18.4% | 10.6% | 12.5% | 2.6% |
| Net Profit Margin | 13.5% | 13.5% | 4.0% | 15.3% | 10.9% | 10.9% | 17.5% | 15.3% | 7.2% | 23.2% | 4.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 26.6% | 26.6% | 6.8% | 24.8% | 18.0% | 20.6% | 33.9% | 24.2% | 10.5% | 45.0% | 9.5% |
| ROA | 15.8% | 15.8% | 4.1% | 14.0% | 9.3% | 11.4% | 21.6% | 18.3% | 8.9% | 37.0% | 6.9% |
| ROIC | 17.0% | 17.0% | 12.6% | 10.3% | 9.5% | 12.8% | 31.7% | 28.9% | 16.5% | 25.2% | 5.4% |
| ROCE | 24.8% | 24.8% | 17.6% | 14.4% | 13.6% | 16.1% | 30.0% | 25.9% | 15.4% | 23.9% | 5.9% |
Solvency and debt-coverage ratios — lower is generally safer
Pro-Dex, Inc. carries a Debt/EBITDA ratio of 1.4x, which is manageable (58% below the sector average of 3.3x). Net debt stands at $16M ($17M total debt minus $419000 cash). Interest coverage of 15.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.45 | 0.45 | 0.44 | 0.47 | 0.63 | 0.63 | 0.37 | 0.27 | 0.00 | 0.01 | 0.01 |
| Debt / EBITDA | 1.39 | 1.39 | 1.63 | 2.23 | 2.73 | 2.73 | 0.91 | 0.84 | 0.01 | 0.04 | 0.06 |
| Net Debt / Equity | — | 0.44 | 0.35 | 0.38 | 0.59 | 0.59 | 0.03 | -0.19 | -0.30 | -0.30 | -0.25 |
| Net Debt / EBITDA | 1.35 | 1.35 | 1.31 | 1.79 | 2.58 | 2.58 | 0.08 | -0.59 | -1.75 | -1.24 | -1.97 |
| Debt / FCF | — | — | 2.09 | 2.64 | — | — | 0.11 | -1.65 | -2.38 | -1.57 | -16.96 |
| Interest Coverage | 15.55 | 15.55 | 5.72 | 18.69 | 13.27 | 17.49 | 34.48 | 22.69 | 486.43 | 237.25 | 31.49 |
Short-term solvency ratios and asset-utilisation metrics
Pro-Dex, Inc.'s current ratio of 3.23x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.71x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.23 | 3.23 | 2.84 | 3.20 | 2.74 | 2.74 | 4.34 | 5.10 | 6.40 | 4.62 | 4.44 |
| Quick Ratio | 1.71 | 1.71 | 1.66 | 1.53 | 1.63 | 1.63 | 2.76 | 3.64 | 4.67 | 3.42 | 2.72 |
| Cash Ratio | 0.49 | 0.49 | 0.53 | 0.42 | 0.14 | 0.14 | 1.72 | 2.43 | 2.92 | 1.91 | 1.10 |
| Asset Turnover | — | 1.09 | 1.03 | 0.89 | 0.86 | 0.86 | 1.12 | 1.06 | 1.13 | 1.34 | 1.81 |
| Inventory Turnover | 2.12 | 2.12 | 2.57 | 2.06 | 2.28 | 2.28 | 2.63 | 2.79 | 3.31 | 4.78 | 4.13 |
| Days Sales Outstanding | — | 95.86 | 94.14 | 78.82 | 133.56 | 133.56 | 54.02 | 55.08 | 67.12 | 60.28 | 53.94 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Pro-Dex, Inc. returns 1.9% to shareholders annually primarily through share buybacks. The earnings yield of 4.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 0.0% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 0.6% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.6% | 6.1% | 3.1% | 10.2% | 7.6% | 3.7% | 8.4% | 7.5% | 5.6% | 20.3% | 3.6% |
| FCF Yield | — | — | 7.4% | 6.5% | — | — | 7.3% | 3.5% | 7.5% | 10.4% | 0.6% |
| Buyback Yield | 1.9% | 2.4% | 5.0% | 2.2% | 2.7% | 4.6% | 4.7% | 7.1% | 0.8% | 1.2% | 2.0% |
| Total Shareholder Yield | 1.9% | 2.4% | 5.0% | 2.2% | 2.7% | 4.6% | 4.7% | 7.2% | 0.8% | 1.2% | 2.0% |
| Shares Outstanding | — | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M |
Compare PDEX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $184M | 21.5 | 16.8 | — | 29.3% | 16.1% | 26.6% | 17.0% | 1.4 | |
| $35M | -26.6 | 33.7 | — | 13.1% | -0.2% | -3.7% | -0.3% | 11.7 | |
| $22M | -2.6 | — | — | 7.6% | -50.3% | -63.1% | -31.1% | — | |
| $1B | -115.8 | 77.7 | 29.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 | |
| $4B | 29.3 | 13.1 | 17.2 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 | |
| $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — | |
| $4B | 27.7 | 17.4 | 70.8 | 34.3% | 12.7% | 16.5% | 11.5% | 2.6 | |
| $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 | |
| $16B | 23.5 | 9.5 | 11.1 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 | |
| $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 | |
| $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 | |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Nortech Systems Incorporated.
Start ComparisonQuick answers to the most common questions about buying PDEX stock.
Pro-Dex, Inc.'s current P/E ratio is 21.5x. The historical average is 22.8x. This places it at the 62th percentile of its historical range.
Pro-Dex, Inc.'s current EV/EBITDA is 16.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.7x.
Pro-Dex, Inc.'s return on equity (ROE) is 26.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 5.1%.
Based on historical data, Pro-Dex, Inc. is trading at a P/E of 21.5x. This is at the 62th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Pro-Dex, Inc. has 29.3% gross margin and 16.1% operating margin. Operating margin between 10-20% is typical for established companies.
Pro-Dex, Inc.'s Debt/EBITDA ratio is 1.4x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.